BioArctic LLY Collaboration Provides Further BrainTransporter Platform Optionality

BioArctic has signed a new research and collaboration agreement with Eli Lilly for its BrainTransporter blood-brain barrier technology. The deal includes $30mn upfront and up to $770mn in potential milestones.

Key Takeaways

• 1.BioArctic announced a new research collaboration with Eli Lilly utilizing the BrainTransporter platform.
• 2.Financial terms include a $30mn upfront payment and up to $770mn in milestone payments plus royalties.

Table of Contents

• Valuation and risks
• Disclosure Appendix
• Price target and rating history chart(s)
• Regulatory disclosures
• Additional disclosures required under the laws and regulations of jurisdictions other than the United States
• Ratings, coverage universe and related definitions

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial